|
Market Closed -
Nasdaq
16:00:00 2024-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 2.350 USD | -.--% |
|
-.--% | - |
| 25-01-13 | Augmedix Wins Vizient Contract for Ambient Ai Documentation Solutions | CI |
| 24-10-02 | Augmedix, Inc.(NasdaqCM:AUGX) dropped from S&P Global BMI Index | CI |
Company Valuation: Augmedix, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Market Cap 1 | 117 | 58.39 | 284 |
| Change | - | -50.11% | 386.43% |
| Enterprise Value (EV) 1 | 90.63 | 54.12 | 263.7 |
| Change | - | -40.29% | 387.23% |
| P/E | -5.1x | -2.39x | -13.4x |
| PBR | 4.97x | 39.8x | 12.2x |
| PEG | 0.1x | -0.41x | 0.4x |
| Capitalization / Revenue | 5.28x | 1.89x | 6.33x |
| EV / Revenue | 4.09x | 1.75x | 5.88x |
| EV / EBITDA | -5.25x | -2.52x | -14.9x |
| EV / EBIT | -5.05x | -2.42x | -14x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.6174 | -0.6534 | -0.4362 |
| Distribution rate | - | - | - |
| Net sales 1 | 22.16 | 30.93 | 44.86 |
| EBITDA 1 | -17.25 | -21.52 | -17.68 |
| EBIT 1 | -17.94 | -22.37 | -18.78 |
| Net income 1 | -17.85 | -24.45 | -19.17 |
| Net Debt 1 | -26.42 | -4.277 | -20.37 |
| Reference price 2 | 3.150 | 1.560 | 5.850 |
| Nbr of stocks (in thousands) | 37,158 | 37,432 | 48,555 |
| Announcement Date | 3/30/22 | 4/17/23 | 3/26/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 116M | ||
| 29.7x | 15.13x | 21.51x | 0.73% | 683B | ||
| 35.77x | 6.55x | 23.27x | 1.01% | 78.78B | ||
| -104.14x | 23.58x | 56.71x | -.--% | 65B | ||
| 22.54x | 4.45x | 9.79x | 0.75% | 64.57B | ||
| 10.8x | 1.44x | 7.39x | 1.02% | 47.01B | ||
| 46.23x | 1.71x | 9.55x | -.--% | 45.99B | ||
| 19.09x | 3.28x | 7.82x | 1.66% | 30.64B | ||
| 20.21x | 6.16x | 11.85x | -.--% | 26.42B | ||
| 9.55x | 2.55x | 6.15x | -.--% | 24.09B | ||
| Average | 9.97x | 7.21x | 17.12x | 0.57% | 106.57B | |
| Weighted average by Cap. | 20.43x | 12.34x | 20.96x | 0.68% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AUGX Stock
- Valuation Augmedix, Inc.
Select your edition
All financial news and data tailored to specific country editions
















